OKYO Pharma Rises Pre-Bell on Chairman's Acquisition of Additional Shares

MT Newswires Live08-23

OKYO Pharma (OKYO) said Friday that Panetta Partners Limited has purchased 50,000 of the company's ordinary shares on Nasdaq at $1.05 per share.

OKYO's Executive Chairman Gabriele Cerrone has a beneficial interest in the entity and the purchase brings his total shareholding to about 9.7 million shares, which is 28.73% of the company's issued share capital, OKYO Pharma said.

OKYO Pharma shares climbed by more than 22% in recent premarket activity on Friday.

Price: 1.3600, Change: +0.32, Percent Change: +30.77

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2461756279?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-23 19:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2461756279","market":"sg","top_or_hot":-1,"title":"OKYO Pharma Rises Pre-Bell on Chairman's Acquisition of Additional Shares","media":"MT Newswires Live","content":"<html><body><p> OKYO Pharma (OKYO) said Friday that Panetta Partners Limited has purchased 50,000 of the company's ordinary shares on Nasdaq at $1.05 per share.</p><p>OKYO's Executive Chairman Gabriele Cerrone has a beneficial interest in the entity and the purchase brings his total shareholding to about 9.7 million shares, which is 28.73% of the company's issued share capital, OKYO Pharma said.</p><p>OKYO Pharma shares climbed by more than 22% in recent premarket activity on Friday.</p><p>Price: 1.3600, Change: +0.32, Percent Change: +30.77</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OKYO Pharma Rises Pre-Bell on Chairman's Acquisition of Additional Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOKYO Pharma Rises Pre-Bell on Chairman's Acquisition of Additional Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-23 19:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>OKYO Pharma (OKYO) said Friday that Panetta Partners Limited has purchased 50,000 of the company's ordinary shares on Nasdaq at $1.05 per share.OKYO's Executive Chairman Gabriele Cerrone has a ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2461756279","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2461756279","pubTimestamp":1724412810,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"OKYO Pharma  said Friday that Panetta Partners Limited has purchased 50,000 of the company's ordinary shares on Nasdaq at $1.05 per share.OKYO's Executive Chairman Gabriele Cerrone has a beneficial interest in the entity and the purchase brings his total shareholding to about 9.7 million shares, which is 28.73% of the company's issued share capital, OKYO Pharma said.OKYO Pharma shares climbed by more than 22% in recent premarket activity on Friday.Price: 1.3600, Change: +0.32, Percent Change: +30.77","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","OKYO":"OKYO Pharma Limited"},"translate_title":"OKYO Pharma因董事长收购额外股份而提高盘前","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OKYO":1},"content_text":"OKYO Pharma (OKYO) said Friday that Panetta Partners Limited has purchased 50,000 of the company's ordinary shares on Nasdaq at $1.05 per share.OKYO's Executive Chairman Gabriele Cerrone has a beneficial interest in the entity and the purchase brings his total shareholding to about 9.7 million shares, which is 28.73% of the company's issued share capital, OKYO Pharma said.OKYO Pharma shares climbed by more than 22% in recent premarket activity on Friday.Price: 1.3600, Change: +0.32, Percent Change: +30.77","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2461756279"}